|
SE0100567D0
(sv)
*
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
AU2002364889A1
(en)
*
|
2001-09-24 |
2003-06-10 |
University Of Aarhus |
Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
|
|
EP1467761B1
(en)
*
|
2001-11-30 |
2006-11-02 |
QLT, Inc. |
Treatment of neovascular ophthalmic disease
|
|
AU2003211424A1
(en)
|
2002-03-01 |
2003-09-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
|
WO2004017950A2
(en)
*
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
|
MXPA06002513A
(es)
*
|
2003-09-04 |
2006-06-20 |
Warner Lambert Co |
Benzo[b]tiofenos halo-sustituidos con actividad inhibidora de fosfoinositido-3-cinasas (pi3k) como agentes terapeuticos.
|
|
SI1709019T1
(sl)
*
|
2004-01-12 |
2007-10-31 |
Serono Lab |
Derivati tiazola in uporaba le-teh
|
|
CA2577478A1
(en)
*
|
2004-08-18 |
2006-02-23 |
Pharmacia & Upjohn Company Llc |
Triazolopyridine compounds
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CN101083996A
(zh)
*
|
2004-10-28 |
2007-12-05 |
Irm责任有限公司 |
作为hedgehog途径调节剂的化合物和组合物
|
|
JP4935357B2
(ja)
|
2004-11-08 |
2012-05-23 |
Ｍｓｄ株式会社 |
新規縮環イミダゾール誘導体
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
|
|
US8481538B2
(en)
*
|
2006-09-18 |
2013-07-09 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic inhibitors of c-Met and uses thereof
|
|
CA2667960A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Novartis Ag |
Imidazopyridazines as pi3k lipid kinase inhibitors
|
|
EP1972631A1
(en)
*
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
|
KR20090094336A
(ko)
|
2006-11-27 |
2009-09-04 |
하. 룬트벡 아크티에 셀스카브 |
헤테로아릴 아미드 유도체
|
|
AR064106A1
(es)
*
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
|
CN101502484B
(zh)
*
|
2006-12-26 |
2011-04-20 |
济南康泉医药科技有限公司 |
同载糖皮质激素和化疗药物的抗癌缓释剂
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
PE20090188A1
(es)
|
2007-03-15 |
2009-03-20 |
Novartis Ag |
Compuestos heterociclicos como moduladores de la senda de hedgehog
|
|
UA101611C2
(ru)
|
2007-04-03 |
2013-04-25 |
Аррей Байофарма Инк. |
СОЕДИНЕНИЯ ИМИДАЗО[1,2-а]ПИРИДИНА КАК ИНГИБИТОРЫ ТИРОЗИНКИНАЗЫ РЕЦЕПТОРОВ
|
|
CA2682925A1
(en)
|
2007-04-10 |
2008-10-16 |
David C. Ihle |
Heteroaryl amide analogues
|
|
US8546394B2
(en)
|
2007-04-17 |
2013-10-01 |
Bristol-Myers Squibb Company |
Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
|
|
PE20090215A1
(es)
*
|
2007-05-09 |
2009-03-30 |
Novartis Ag |
Compuestos derivados de imidazopiridazinas como inhibidores de cinasa
|
|
WO2008141731A2
(en)
*
|
2007-05-18 |
2008-11-27 |
Bayer Healthcare Ag |
Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
|
|
EP2062893A1
(en)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fused imidazoles for cancer treatment
|
|
WO2009021990A1
(en)
*
|
2007-08-14 |
2009-02-19 |
Bayer Schering Pharma Aktiengesellschaft |
Fused imidazoles for cancer treatment
|
|
EP2203439B1
(en)
|
2007-09-14 |
2011-01-26 |
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
|
|
CN101848893B
(zh)
|
2007-09-14 |
2012-06-06 |
奥梅-杨森制药有限公司 |
1,3-二取代的4-(芳基-x-苯基)-1h-吡啶-2-酮
|
|
EP2060565A1
(en)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
|
|
EA201000797A1
(ru)
*
|
2007-11-27 |
2011-02-28 |
Целльзом Лимитид |
Аминотриазолы в качестве ингибиторов pi3k
|
|
CN101981033B
(zh)
|
2008-02-06 |
2015-02-04 |
百时美施贵宝公司 |
用作激酶抑制剂的取代的咪唑并哒嗪化合物
|
|
AR070487A1
(es)
|
2008-02-28 |
2010-04-07 |
Novartis Ag |
Derivados de 3- metil- imidazo -( 1,2-b)- piridazina
|
|
WO2009126624A1
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as dgat1 inhibitors
|
|
WO2009126861A2
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as dgat1 inhibitors
|
|
EP2303841A1
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Oxindolyl inhibitor compounds
|
|
WO2010009139A2
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Colorado, Inc. |
Imidazolyl pyrimidine inhibitor compounds
|
|
WO2010009155A2
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Colorado, Inc. |
Fused heterocyclyc inhibitor compounds
|
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
MX2011001090A
(es)
|
2008-07-28 |
2011-03-15 |
Gilead Sciences Inc |
Compuestos de inhibidor de desacetilasa de histona de cicloalquilideno y heterocicloalquilideno.
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
|
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
MX2011002042A
(es)
|
2008-09-02 |
2011-06-20 |
Ortho Mcneil Janssen Pharm |
Derivados de 3-azabiciclo[3.1.o]hexilo como moduladores de los receptores del glutamato metabotropico.
|
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
|
WO2010060589A1
(en)
|
2008-11-28 |
2010-06-03 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
|
WO2010074586A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Pathway Therapeutics Limited |
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
|
|
WO2010117926A1
(en)
|
2009-04-07 |
2010-10-14 |
Schering Corporation |
Substituted triazolopyridines and analogs thereof
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
JP5707390B2
(ja)
|
2009-05-12 |
2015-04-30 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド |
１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体の正のアロステリック調節因子としてのその使用
|
|
EP2430022B1
(en)
|
2009-05-12 |
2013-11-20 |
Janssen Pharmaceuticals, Inc. |
1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
|
AU2010259042A1
(en)
|
2009-06-08 |
2011-12-15 |
Gilead Sciences, Inc. |
Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
|
|
EP2440519A1
(en)
|
2009-06-08 |
2012-04-18 |
Gilead Sciences, Inc. |
Alkanoylamino benzamide aniline hdac inihibitor compounds
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
JP5781510B2
(ja)
|
2009-08-12 |
2015-09-24 |
ノバルティス アーゲー |
ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用
|
|
MX2012002179A
(es)
|
2009-08-20 |
2012-03-16 |
Novartis Ag |
Compuestos heterociclicos de oxima.
|
|
EP2496578A4
(en)
|
2009-11-05 |
2013-08-21 |
Univ Notre Dame Du Lac |
IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
|
|
CA2779951A1
(en)
*
|
2009-11-06 |
2011-05-12 |
Piramal Life Sciences Limited |
Imidazopyridine derivatives
|
|
JP5774602B2
(ja)
*
|
2009-12-30 |
2015-09-09 |
アークル インコーポレイテッド |
置換されたイミダゾピリジニル−アミノピリジン化合物
|
|
EP2563792B1
(en)
|
2010-04-28 |
2014-08-27 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
|
WO2012062750A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
CA2814998C
(en)
|
2010-11-08 |
2019-10-29 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
WO2012068204A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Janssen Pharmaceutica Nv |
Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
|
|
EP2655362A1
(en)
|
2010-12-22 |
2013-10-30 |
Abbvie Inc. |
Hepatitis c inhibitors and uses thereof
|
|
CN102030752A
(zh)
*
|
2011-01-06 |
2011-04-27 |
贵阳中医学院 |
一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙腈的方法
|
|
TW201242965A
(en)
|
2011-02-01 |
2012-11-01 |
Kyowa Hakko Kirin Co Ltd |
Ring-fused heterocyclic derivative
|
|
JP6039585B2
(ja)
|
2011-02-25 |
2016-12-07 |
アレイ バイオファーマ、インコーポレイテッド |
Ｐｉｍキナーゼ阻害剤としてのトリアゾロピリジン化合物
|
|
PT2694510E
(pt)
|
2011-04-07 |
2016-02-08 |
Bayer Pharma AG |
Imidazopiridazinas como inibidores da akt quinase
|
|
WO2012156379A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Universität Zürich |
PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING
|
|
KR101274986B1
(ko)
*
|
2011-07-27 |
2013-06-17 |
한국과학기술원 |
이미다조피리딘 유도체, 이를 포함하는 ＰＩ3Ｋ 및/또는 ｍＴＯＲ 저해제용 약학 조성물 및 ＰＩ3Ｋ 및/또는 ｍＴＯＲ과 연관된 질환 치료용 약학 조성물
|
|
US9540366B2
(en)
|
2012-07-31 |
2017-01-10 |
Kyowa Hakko Kirin Co., Ltd. |
Ring-fused heterocyclic compound
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
JP6056872B2
(ja)
*
|
2012-11-30 |
2017-01-11 |
アステラス製薬株式会社 |
イミダゾピリジン化合物
|
|
EA201591360A1
(ru)
|
2013-02-19 |
2016-03-31 |
Пфайзер Инк. |
Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
|
|
ES2625744T3
(es)
|
2013-06-04 |
2017-07-20 |
Bayer Pharma Aktiengesellschaft |
Imidazo[1,2-a]piridinas sustituidas con 3-arilo y su uso
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
AU2015208233B2
(en)
|
2014-01-21 |
2019-08-29 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
PT3105218T
(pt)
|
2014-02-13 |
2019-12-05 |
Incyte Corp |
Ciclopropilaminas como inibidores de lsd1
|
|
EP3105219B9
(en)
|
2014-02-13 |
2018-10-03 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
DK3105226T3
(da)
|
2014-02-13 |
2019-10-14 |
Incyte Corp |
Cyclopropylaminer som lsd1-inhibitorer
|
|
CA2939793A1
(en)
|
2014-02-19 |
2015-08-27 |
Bayer Pharma Aktiengesellschaft |
3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
|
|
WO2015140199A1
(de)
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
CA2938923A1
(en)
*
|
2014-03-24 |
2015-10-01 |
Arqule Inc. |
Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
|
|
EP3653627A1
(en)
*
|
2014-04-22 |
2020-05-20 |
ArQule, Inc. |
Polymorphs of a substituted imidazopyridinyl-aminopyridine compound
|
|
EP3137463A1
(de)
|
2014-05-02 |
2017-03-08 |
Bayer Pharma Aktiengesellschaft |
Enantiomere des n-(2-amino-5-fluor-2-methylpentyl)-8-[(2,6-difluorbenzyl)oxy]-2-methylimidazo[1,2-a]pyridin-3-carboxamids sowie der di- and tri-fluor-derivate zur behandlung von kardiovaskulären erkrankungen
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
TWI687419B
(zh)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
EP3172210B1
(en)
|
2014-07-24 |
2020-01-15 |
Pfizer Inc |
Pyrazolopyrimidine compounds
|
|
PT3177624T
(pt)
|
2014-08-06 |
2019-07-11 |
Pfizer |
Compostos de imidazopiridazina
|
|
EP3227287B1
(de)
|
2014-12-02 |
2019-08-07 |
Bayer Pharma Aktiengesellschaft |
Heteroaryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
|
|
EP3626720A1
(en)
|
2015-04-03 |
2020-03-25 |
Incyte Corporation |
Heterocyclic compounds as lsd1 inhibitors
|
|
KR102710120B1
(ko)
|
2015-08-12 |
2024-09-27 |
인사이트 홀딩스 코포레이션 |
Lsd1 저해제의 염
|
|
AU2016324598A1
(en)
|
2015-09-17 |
2018-03-15 |
Marvin J. Miller |
Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
CN107304203A
(zh)
*
|
2016-04-20 |
2017-10-31 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
|
WO2017181973A1
(zh)
*
|
2016-04-20 |
2017-10-26 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
|
PE20190377A1
(es)
|
2016-04-22 |
2019-03-08 |
Incyte Corp |
Formulaciones de un inhibidor de lsd 1
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
WO2018013430A2
(en)
|
2016-07-12 |
2018-01-18 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus infection
|
|
WO2018184976A1
(de)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
CN111225917A
(zh)
|
2017-10-24 |
2020-06-02 |
拜耳股份公司 |
取代咪唑并吡啶酰胺及其用途
|
|
IL279977B2
(en)
|
2018-07-09 |
2024-06-01 |
Boehringer Ingelheim Animal Health Usa Inc |
Heterocyclic anthelmintic compounds
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
US12419865B2
(en)
|
2018-12-06 |
2025-09-23 |
Arisan Therapeutics Inc. |
Compounds for the treatment of arenavirus infection
|
|
CA3133100A1
(en)
|
2019-03-19 |
2020-09-24 |
Boehringer Ingelheim Animal Health USA Inc. |
Anthelmintic aza-benzothiophene and aza-benzofuran compounds
|
|
WO2020216669A1
(de)
|
2019-04-23 |
2020-10-29 |
Bayer Aktiengesellschaft |
Phenylsubstituierte imidazopyridinamide und ihre verwendung
|
|
TWI879949B
(zh)
*
|
2020-04-27 |
2025-04-11 |
南韓商奧土擇破利悟股份有限公司 |
用於ｕｂｒ盒結構域配體之化合物、組成物以及醫藥組成物
|
|
MX2022015038A
(es)
|
2020-05-29 |
2023-01-04 |
Boehringer Ingelheim Animal Health Usa Inc |
Compuestos heterociclicos como anthelminticos.
|
|
CN113135913B
(zh)
*
|
2021-04-28 |
2022-05-24 |
沈阳药科大学 |
3-取代基-6-吡啶类取代基-六元并五元杂环类衍生物及其制法与用途
|
|
IL312412A
(en)
|
2021-11-01 |
2024-06-01 |
Boehringer Ingelheim Vetmedica Gmbh |
Pyrrolopyridazine compounds against worms
|